RS Research has been founded in 2015
as an academic spin-off by
Rana Sanyal and Sena Nomak.
We raised 2 million Euros from
technology focused venture capital fund
ACT Venture Partners.
Our production facility was
granted GMP license for clinical batch
lyophilized oncology drugs.
In consequence of promising results from
pre-clinical studies, we started
RS-0139’s phase-I clinical trial in NSCLC.